APA (7th ed.) Citation

Naik, H. B., Pichard, D. C., Schwartz, D. M., O'Brien, M., Masciocchi, M., Thompson, J., . . . Cowen, E. W. (2022). Anakinra for refractory pustular psoriasis: A phase II, open-label, dose-escalation trial. Journal of the American Academy of Dermatology, 87(6), 1380-1383. https://doi.org/10.1016/j.jaad.2022.07.065

Chicago Style (17th ed.) Citation

Naik, Haley B., et al. "Anakinra for Refractory Pustular Psoriasis: A Phase II, Open-label, Dose-escalation Trial." Journal of the American Academy of Dermatology 87, no. 6 (2022): 1380-1383. https://doi.org/10.1016/j.jaad.2022.07.065.

MLA (9th ed.) Citation

Naik, Haley B., et al. "Anakinra for Refractory Pustular Psoriasis: A Phase II, Open-label, Dose-escalation Trial." Journal of the American Academy of Dermatology, vol. 87, no. 6, 2022, pp. 1380-1383, https://doi.org/10.1016/j.jaad.2022.07.065.